2025-523980-39-00招募中1 期
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Lilly Clinical Trials information desk
Scientific
Eli Lilly & Co.
研究点 (1)
Loading locations...
相似试验
招募中
1 期
A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment2025-521947-19-00Eli Lilly & Co.26
招募中
1 期
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)Ovarian Neoplasms
Breast Neoplasms
Pancreatic Intraductal Neoplasms
Colorectal Neoplasms
Esophageal Neoplasms
Stomach Neoplasms
CholangiocarcinomaOvarian Neoplasms Breast Neoplasms Pancreatic Intraductal Neoplasms Colorectal Neoplasms Esophageal Neoplasms Stomach Neoplasms Cholangiocarcinoma2025-521887-37-00Eli Lilly & Co.64
招募中
1 期
A Study of LY4257496 in Participants With Cancer (OMNIRAY)Breast Neoplasms Colorectal Neoplasms Prostate Neoplasm Endometrial Neoplasms Neoplasm Metastasis Stomach Neoplasms Esophageal Neoplasms2025-522367-15-00Eli Lilly & Co.53
招募中
1 期
A Phase 1 Study on the effects of LY3410738 (study drug) administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations2024-515150-24-00Eli Lilly & Co.3
已完成
1 期
A study in healthy people to test whether BI 1291583 influences the amount of dabigatran in the body2024-516256-18-00Boehringer Ingelheim International GmbH14